SCROLL NEWS / DISCOVERY

Search headlines

Find the stories shaping the conversation.

Search mode
Refine results
Active filters Keyword All time

Results for " Biopsy " 12 found 🔀 AI-powered Shuffle

Guardant Health to Highlight Advances in Liquid Biopsy for Cancer Monitoring at ESMO 2026

Guardant Health and partners will present 25 abstracts on liquid biopsy advances for cancer monitoring at ESMO 2026.

clpmag.com logo
Oct 20 • 11:32 AM EDT • Health • clpmag.com
Caris Life Sciences Unveils the Next Evolution of Liquid Biopsy with Enhanced Caris Assure

/PRNewswire/ -- Caris Life Sciences® (Caris), a leading AI TechBio company, today unveiled the enhanced Caris Assure®, a new evolution of liquid biopsy. By...

prnewswire.com logo
Sep 29 • 6:30 AM EDT • Science • prnewswire.com
The Liquid Biopsy That Found Pancreatic Cancer Early Has a Bigger Regulatory Problem Than Its Science

PANXEON detects stage 1-2 pancreatic cancer with 87% sensitivity, but FDA's companion diagnostic pathway may be the bigger obstacle to clinical adoption.

clinicaltrialvanguard.com logo
Sep 21 • 3:29 AM EDT • Science • clinicaltrialvanguard.com
Guardant Health (GH) Will Present 20 Abstracts At WCLC 2026

Guardant Health (NasdaqGS:GH) plans to present 20 abstracts at the World Conference on Lung Cancer 2026. The research covers liquid biopsy, methylation based detection methods, AI driven analysis and real world clinical data in lung cancer. Several abstracts focus on machine learning models aimed at assessing metastasis risk and refining diagnostic workflows for clinicians. Guardant Health's WCLC 2026 abstract slate signals broader research momentum that our work places in a wider context...

simplywall.st logo
Sep 19 • 6:26 PM EDT • Health • simplywall.st
Guardant Health (GH) Lands First FDA Cleared Breast Cancer Liquid Biopsy Role

Guardant Health (NasdaqGS:GH) received FDA approval for its Guardant360 CDx liquid biopsy as a companion diagnostic in advanced HR-positive, HER2-negative breast cancer. The decision makes Guardant360 CDx the first FDA approved liquid biopsy companion diagnostic for longitudinal ctDNA testing in breast cancer care. The approval is supported by clinical trial data where early detection of ESR1 mutations using Guardant360 CDx informed treatment changes for patients. The Guardant360 CDx breast...

finance.yahoo.com logo
Sep 18 • 1:14 AM EDT • Health • finance.yahoo.com
Vanderbilt awarded $3.4M grant to advance MR cytometry for breast cancer imaging

The approach could complement biopsy results by providing a noninvasive way to assess tumor microstructure.

radiologybusiness.com logo
Aug 27 • 10:45 PM EDT • Business • radiologybusiness.com
The COVID-19 vaccine may offer brain cancer patients a surprise benefit

A recent shot of the COVID-19 vaccine doubled survival time in glioblastoma patients who had undergone tumor biopsy or surgery.

sciencenews.org logo
Aug 17 • 10:00 AM EDT • Science • sciencenews.org
Katie Thurston Delays Biopsy, New Treatment for Stage 4 Breast Cancer for 'Mental Health Reasons’: ‘I Need a Break’

Katie Thurston has been open about her fear of needles and the emotional toll of her stage 4 breast cancer journey. The ‘Bachelorette’ alum said she’s now pushing back a biopsy and new treatment to prioritize her mental health.

people.com logo
Jun 15 • 12:32 PM EDT • Health • people.com
American College of Radiology urges FDA to address breast biopsy needle shortages

“According to widespread reports from the breast imaging community, these shortages are creating immediate and substantial challenges for breast imaging practices nationwide," ACR warned the FDA in a letter May 11.

radiologybusiness.com logo
May 15 • 1:55 AM EDT • Business • radiologybusiness.com
Woman in cancer remission without treatment in highly unusual case

A biopsy of a woman's cancer seems to have triggered an immune response against the tumour, putting her into remission

newscientist.com logo
May 5 • 5:00 AM EDT • Health • newscientist.com
Guardant Health (GH) Valuation Check After Strong 1 Year Return And Recent 90 Day Pullback

Guardant Health (GH) has drawn fresh attention as investors look at its recent share performance alongside its growing precision oncology business, including liquid biopsy tests and data services for cancer detection and treatment decisions. See our latest analysis for Guardant Health. At a latest share price of US$93.83, Guardant Health has seen a sharp 10.9% 7 day share price return and a 1 year total shareholder return above 100%. However, the 90 day share price return of a 7.77% decline...

finance.yahoo.com logo
Apr 4 • 7:07 PM EDT • Health • finance.yahoo.com
Democrats decry meager medical care for detainees in funding fight

Fernando Viera Reyes needed a biopsy for possible prostate cancer when the Trump administration sent him to an immigration detention center in California’s Mojave Desert.

cnn.com logo
Feb 23 • 4:00 AM EST • Health • cnn.com
Deep dive
😐 Neutral (1%)
love
38%
wow
35%
ahah
27%